透析患者继发性甲旁亢甲状旁腺切除术的再入院与费用:住院与门诊比较
该研究基于美国五个州2013–2019年数据库,纳入1267例透析依赖的继发性甲旁亢患者,比较住院与门诊甲状旁腺切除术的30天再入院、并发症和费用。调整后住院与门诊再入院率相似(14% vs 15%,P=0.79),门诊调整后中位费用显著更低($6357 vs $9615,P<0.001)。部分选择性患者可安全接受门诊手术并降低费用。
要点
- 透析患者继发性甲旁亢门诊甲状旁腺切除术占37%,其中40%过夜、42%当日出院。
- 调整后住院与门诊30天再入院率相似(14% vs 15%,P=0.79)。
- 门诊手术调整后中位费用显著低于住院($6357 vs $9615,P<0.001)。
核心结论
- 选择性继发性甲旁亢透析患者可安全接受门诊甲状旁腺切除术,且费用更低。
研究设计与样本
- 回顾性队列研究,利用HCUP五个州住院和门诊手术数据库(2013–2019),纳入1267例透析依赖的继发性甲旁亢行择期甲状旁腺切除术的成人患者。
主要发现
- 1267例中63%为住院手术;门诊手术中40%过夜、42%当日出院。
- 住院患者更年轻、黑人比例更高、非私人保险更多、合并症更多(P<0.05)。
- 总体再入院率19%;住院再入院22% vs 门诊15%(P=0.002),平衡权重调整后14% vs 15%(P=0.79)。
- 过夜与当日出院再入院率相似(未调整12% vs 15%,P=0.47;调整后15% vs 15%,P=0.97)。
- 门诊患者中,甲状旁腺自体移植、焦虑障碍、自身免疫病、充血性心力衰竭和中重度肝衰竭与再入院风险显著增加相关。
临床怎么用
- 对合并症少、无特定风险因素(如焦虑障碍、自身免疫病、心衰、肝衰竭、甲状旁腺自体移植)的透析继发性甲旁亢患者,可考虑门诊甲状旁腺切除术以降低费用。
局限性
- 研究为回顾性设计,仅纳入五个州数据,可能存在选择偏倚和未测量混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: Among patients with kidney failure treated with dialysis, 37% underwent parathyroidectomy in the outpatient setting. Significant differences exist between patients selected for inpatient versus outpatient parathyroidectomy. Risk-adjusted readmission rates are similar after inpatient or outpatient parathyroidectomy for secondary hyperparathyroidism. BACKGROUND: Outpatient parathyroidectomy for secondary hyperparathyroidism of kidney disease is increasing. Reduced length of stay is often associated with higher rates of readmission. The safety of outpatient parathyroidectomy in this population must be evaluated given the morbidity and higher risk of post-parathyroidectomy hungry bone syndrome associated with kidney failure. In this study, we compare parathyroidectomy outcomes and costs by admission status in dialysis-dependent patients with secondary hyperparathyroidism. METHODS: Adult patients on dialysis who underwent elective parathyroidectomy for secondary hyperparathyroidism were identified in the Healthcare Cost and Utilization Project State Inpatient and State Ambulatory Surgery Databases from five geographically diverse states (2013–2019). Patients were classified by admission status: inpatient and outpatient (overnight or same-day). The primary outcome was 30-day readmission. Secondary outcomes were parathyroidectomy-related complications and cost. Outcomes were compared by admission status using chi-squared tests and costs using median quantile regression. Balancing weights were used for adjustment. Forward selection with logistic regression was used to identify factors associated with readmission among outpatients. RESULTS: Among 1267 study participants, 63% were inpatients. Among outpatients, 40% underwent overnight stay and 42% underwent same-day discharge. Inpatients were more likely to be younger, Black race, have nonprivate insurance, and increased comorbidities than outpatients (P < 0.05). Overall readmission rate was 19%. Readmission was higher among inpatients (Inpatient: 22% versus Outpatient: 15%; P = 0.002). After balancing weights, adjusted 30-day readmission rate was similar between inpatients and outpatients (14% versus 15%; P = 0.79). Readmission was similar between overnight stay and same-day discharge (Unadjusted: 12% versus 15%; P = 0.47. Adjusted: 15% versus 15%; P = 0.97). Outpatients with parathyroid autotransplantation, anxiety disorder, autoimmune conditions, congestive heart failure, and moderate/severe liver failure had significantly increased odds of readmission after parathyroidectomy. Adjusted median costs varied significantly (Adjusted Inpatient: $9615 [Interquartile range (IQR), $6463–12,963] versus Outpatient: $6357 [IQR, $4966–8153]; P < 0.001; Adjusted Overnight: $6453 [IQR, $5551–7850] versus Same-day: $5526 [IQR, $4346–7187]; P < 0.001). CONCLUSIONS: Select patients with secondary hyperparathyroidism may undergo outpatient parathyroidectomy safely with reduced costs.
引用
- Hwang J, Sharpe J, Finn C, et al. Readmission and Cost of Parathyroidectomy By Admission Status in Secondary Hyperparathyroidism. Clin J Am Soc Nephrol. 2025. PMID: 41369937. doi:10.2215/CJN.0000000809
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。